SKSagar Khadanga

Sagar Khadanga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sagar Khadanga has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Postmortem Blood Procalcitonin (PCT) for identifying sepsis as a cause of death: a systematic review and meta-analysis

    by Aswini Chandran, Sagar Khadanga, Ayush Gupta, Diksha Chhabra, Arun Kori, Leena Lokhande, Moirangthem Sangita, Amit Agrawal, Arneet Arora

  • Open Access

    Reintroducing antitubercular therapy after drug-induced liver injury: A narrative review of protocols

    by Shaurya Tewari, Sagar Khadanga

    Drug-induced liver injury (DILI) is a frequent and serious complication of first-line antitubercular therapy (ATT), with significant morbidity and mortality. Reintroduction of ATT post-DILI is essential due to the limited efficacy and higher toxicity of second-line drugs. This narrative review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses principles to evaluate existing evidence on ATT reintroduction protocols, including concomitant, sequential, and incremental approaches. A comprehensive search of PubMed up to August 2024 identified eight relevant studies comprising randomized controlled trials, cohort studies, and a systematic review. Across studies, recurrence rates ranged from 6.9% to 18%, with pyrazinamide most frequently implicated. Incremental regimens demonstrated a trend toward lower recurrence rates, although statistical significance was inconsistent. Sequential and concomitant approaches showed comparable outcomes. Patient-related factors such as hypoalbuminemia, low body mass index, female sex, and elevated bilirubin levels were associated with increased risk of recurrence. Current evidence is limited, and individualized treatment plans based on clinical judgment remain necessary. There is a clear need for well-designed studies to establish safe and effective reintroduction protocols.

  • Decoding moxifloxacin resistance in pre-XDR tuberculosis using MGIT 960 and MYCOTB AST

    by D Daniel Raj, Anand Kumar Maurya, Shashank Purwar, Sagar Khadanga, Jitendra Singh, Alkesh Kumar Khurana, Sowmya Dhawan, Debasis Biswas

  • Open Access

    Emergence of a Novel Dengue Virus Serotype-2 Genotype IV Lineage III Strain and Displacement of Dengue Virus Serotype-1 in Central India (2019–2023)

    by Ashish Kumar Yadav, Rashmi Chowdhary, Arshi Siddiqui, Anvita Gupta Malhotra, Jagat R. Kanwar, Ashok Kumar, Debasis Biswas, Sagar Khadanga, Rajnish Joshi, Abhijit Pakhare, et al.

    Dengue fever remains a significant public health concern in tropical regions, including Central India, where outbreaks are frequent and associated with high morbidity and mortality. This study investigated the dynamics of dengue virus transmission and evolution in Central India from 2019 to 2023, focusing on the emergence of new strains and their impact on outbreak patterns. For this, 40 mosquito pools and 300 patient samples were recruited for the study. Phylogenetic and Bayesian evolutionary analyses performed on CPrM region and whole genome sequences generated by Sanger and Illumina sequencing, respectively, revealed the emergence and predominance of a novel DENV-2 genotype IV lineage III strain in the 2019 and 2023 outbreaks, which displaced the previously circulating DENV-1 genotype responsible for the 2016–2017 outbreak. Despite pre-existing DENV-1 neutralizing antibodies in the community (67 healthy volunteers), the novel DENV-2 strain exhibited higher viral loads and a greater reproduction number (R0), contributing to rapid disease spread. Molecular clock and Shannon entropy analyses suggest that DENV evolution occurred within the mosquito vector, driven by natural selection. Our findings highlight the importance of continuous DENV surveillance, including genetic characterization in both vectors and hosts, to understand viral evolution and predict future outbreaks. Rapid urbanization and inadequate sanitation in densely populated regions like India create ideal breeding grounds for mosquitoes, facilitating the introduction and establishment of novel DENV strains. Interrupting the vector–DENV–host cycle through targeted interventions is crucial for effective dengue control.


  • Open Access

    Incremental cost of treating antimicrobial-resistant infections among hospitalised patients in India: a cohort study

    by Abhijit Kadam, Megha Mamulwar, Gayatri Bhambure, Shilpa Bembalkar, Shraddha Bapat, Arati Mane, Shobha Rajure, Jayanthi Mathaiyan, Nusrat Shafiq, Shankar Prinja, et al.

    Background: Accurate estimates of incremental cost (IC) attributable to antimicrobial resistance (AMR) provide information of immense public health importance to the policy makers. Here, we present the IC from patient perspective for treating antimicrobial-resistant pathogens in India. Methods: This cohort study was conducted in eight hospitals including government (GH), private (PH) and trust hospitals (TH), considering their ownership, geographical location and categories of cities. This study had a retrospective component, which calculated the direct cost of treating resistant and susceptible blood stream infections caused by selected WHO priority pathogens. The prospective component estimated indirect cost and financial coping strategies for the treatment of AMR. In the retrospective component, 1723 records were included and 170 patients were recruited in the prospective component. Results: The median total cost for management of antimicrobial-resistant infections was US$199 (IQR 89, 377) as opposed to US$109 (IQR 55, 229) for susceptible infection in GH. Our study has revealed that the ICs for Enterobacteriaceae (53.9%), Acinetobacter (43.8%) and Staphylococcus (49.7%) at GHs were higher for resistant pathogens. Pharmaceutical cost was the major contributor to IC at GHs (61.5%) and PHs (27.1%). In the prospective component, 46.5% of patients resorted to borrowing money for hospitalisation expenses and the per day median total cost for resistant and sensitive infection was estimated to be US$65 and US$35, respectively. Conclusions: The current study concluded that the presence of any critical or high priority pathogens led to an increase in the direct and indirect medical costs. The IC varied with hospital type, length of stay, pathogen, comorbidities and diagnosis. Prospective studies are needed for precise understanding of variations in the costs of treating AMR infections.


  • Open Access

    Prevalence of Intestinal Parasitic Infections and Associated Risk Factors Among the Households of Migrant Construction Workers at Bhopal

    by Akhila Reddy, Khadanga Sagar, Pradeep Kumar Gupta, Tadepalli Karuna

    Intestinal Parasitic infections are one of the most common infections in tropics. There is paucity of data on prevalence of intestinal parasite infections among migrant construction workers and their house holds so this study was taken up. A cross sectional study was conducted for eight months with an aim to determine the prevalence and assess the associated risk factors among the households of migrant construction workers at AIIMS Bhopal. A semi-structured interview questionnaire survey was conducted prior to collection of stool samples. Each stool sample was examined macroscopically followed by occult blood testing. Wet mount observation was followed by modified acid fast staining and formal ether sedimentation. Recruits with pathogenic parasites in any of the three samples were considered positive and treated as per the national guidelines for age, drug and dose by clinical consultation. 361 participants were recruited. 122/361 (33.8%) were between 21 to 30 years. 55.2% females, 47.4% had occupation of digging soil, 93.1% practiced open field defecation. 36.9% (133/361) was the prevalence of intestinal parasitic infection. 88.7% monoinfection, E.histolytica/dispar (41%) and H.nana( 10.2%) were most prevalent parasites. 26.7%) was commonest. 11.28%coinfection, G. intestinalis with A. duodenale (26.7%) was commonest. In our study only hand washing was independent predictor having Odds Ratio of 3.6 with confidence interval 1.00-13.00(those who don’t wash hands before meals are 3.6 times more likely to develop infection). Only few studies address migrant construction workers, their nomadic behaviour makes them vulnerable for intestinal parasitic infections and not benefitting from prevention programmes as deworming programme.


  • Open Access

    Indian Classical Music, Raaga as music therapy: scope and opportunities

    by Varun Malhotra, Samidha Vedabala, Sagar Khadanga, Anvesh Jallapally, Murlimanju Bv, Saikat Das, Amit Agrawal

    The existing research on Indian classical music therapy faces several challenges that need attention for the field’s growth and credibility. Most studies rely on anecdotal evidence rather than rigorous scientific methodology, necessitating more controlled trials and longitudinal research. The rich diversity of ragas and talas in Indian classical music poses a challenge in standardizing their therapeutic application. Cultural sensitivity is crucial due to the deeply rooted nature of this therapy in Indian culture, and generalizing findings to diverse populations requires careful consideration. Music therapy is gaining recognition worldwide, with universities offering courses ranging from certificates to doctorates. Music therapy is considered a deep-rooted treatment for mental and physical health, with the ability to heal at a fundamental level. Music’s therapeutic effects include encouraging socialization, self-expression, and motor development, and it can be both motivating and calming. Ancient Indian traditions like yoga, meditation, and ‘raga chikitsa’ offer therapies for stress-related physical and psychological ailments. Researchers suggest measuring cortisol levels and endorphins to understand the neuroendocrine effects of music. The research has explored how Indian melodies can influence physiological measures linked to stress, arousal, and anxiety, and revealed that musical modes can induce behavioral and cardiovascular changes in participants. To explore these benefits, consult a qualified music therapist or healthcare professional for tailored guidance. Importantly, music therapy should complement, not replace, conventional medical treatment when necessary. Additionally, studying the duration of music therapy for different diseases is essential for scientific understanding.


  • Open Access

    The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis

    by Manaswinee Mallik, Abhishek Singhai, Sagar Khadanga, Vaibhav Ingle

    Background: Cirrhosis progression varies greatly from patient to patient due to a variety of factors, including hepatic reserve, cirrhosis etiology, and the presence of hepatocellular cancer. As a result, determining a prognosis in a patient with cirrhosis remains a difficult task. For nearly three decades, the Child-Pugh score (CPS) has been the gold standard for determining the prognosis of cirrhosis. In the last two decades, many prognostic models and scores like a model for end-stage liver disease (MELD), chronic liver failure-sequential organ failure assessment (CLIF-SOFA) score, peripheral blood lymphocyte to monocyte ratio (LMR) have been presented to predict prognosis in patients with cirrhosis and to choose the best therapy option. The aim of our study is to determine which score is more effective in predicting three-month mortality and whether these scores are equally effective in predicting short-term outcomes. Materials & methods: In this hospital-based longitudinal study, we analyzed 140 patients with cirrhosis of liver visiting All India Institute of Medical Sciences Bhopal between July 2019 and July 2020. All the 140 patients were followed up for three months to establish short-term outcomes. The blood investigations were done at the time of presentation from all the patients and after three months in the survivors. Various scores were calculated. Results: The majority of patients (47%) were in Child-Pugh class C. Mean MELD score was 13.54, LMR score was 1.96 and CLIF-SOFA score was 5. The total bilirubin, serum creatinine, international normalized ratio (INR), total leukocyte count, absolute monocyte count, CPS, MELD, CLIF-SOFA were significantly higher in a non-surviving group as compared to the surviving group, whereas the albumin and LMR significantly decreased in the non-surviving group. On performing multivariate regression, LMR and CLIF-SOFA were significant independent risk factors of mortality after adjusting for confounding factors. All the parameters had significant discriminatory power to predict mortality. Discriminatory power of CLIF-SOFA (AUC 0.808; 95% CI: 0.733 to 0.870) was excellent and discriminatory power of CPS (AUC 0.792; 95% CI: 0.716 to 0.856), MELD score (AUC 0.765; 95% CI: 0.685 to 0.832) and LMR (AUC 0.75; 95% CI: 0.669 to 0.819) was acceptable. Among all the parameters, CLIF-SOFA was the best predictor of mortality at a cut-off point of >5 with 80.80% chances of correctly predicting mortality. Conclusion: The significant morbidity and mortality indicators are high total bilirubin, high creatinine, high INR, high TLC, low platelet count, and low albumin. Among the various scores, CLIF-SOFA is a better predictor of mortality and morbidity. Low LMR and high CLIF-SOFA are significant independent risk factors of mortality at three months.


  • Open Access

    Impact of an Anti-Microbial Stewardship Program on Targeted Antimicrobial Therapy in a Tertiary Care Health Care Institute in Central India

    by Rahul Garg, Gyanendra Singh, Shweta Kumar, Mamta Verma, Lily Podder, Vaibhav Ingle, Abhishek Singhai, T Karuna, Saurabh Saigal, Kamini Walia, et al.

    Antimicrobial resistance (AMR) has become a global pandemic. In order to identify this menace, World Health Organisation (WHO) has developed the Global Action Plan on AMR (GAP AMR). Antimicrobial stewardship programs (AMSP) have been identified as a decisive tool for combating AMR. One of the most efficient measures of these programs has been the implementation of point prevalence surveys (PPS) of antibiotic usage and subsequent audit feedback. The present study was undertaken to identify the impact of AMSP on curtailing of empirical usage of antibiotics and the augmentation of targeted therapy. It is an observational, cross-sectional study comprising 1396 patients. The microbiology culture details and anti-microbial-sensitivity results were recorded. Antibiotic prescriptions were recorded in each patient during their hospital stay. Out of 1396 patients treated over four quarters (Q1-Q4), 711 (50.9%) patients were on antibiotics, and among them, only 415 patients were subjected to any microbiological cultures with an overall bacterial culture rate (BCR) of 58.3%, and 296 patients (41.6%) were treated with antibiotics empirically without sending any samples for bacterial culture. There was a statistically significant rise in BCR from 47.3% in the first quarter to 77.6% in the fourth quarter. Sending specimens for blood culture increased significantly from 29.2% in Q1 to 37.6% in Q4. After receiving culture reports, 72.3% of cases continued with the same antibiotic, the antibiotic was changed in 19.9% of cases, and the antibiotic was stopped in 7.8% of cases. There was a strong positive impact of AMSP in curtailment of empirical usage of antibiotics and augmenting targeted therapy as evidenced by the significant rise in BCR over Q1-Q4 PPS as well as a significant rise in ordering for blood culture over the same time period.


  • Open Access

    Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19

    by Mahejibin Khan, Bijina J. Mathew, Priyal Gupta, Garima Garg, Sagar Khadanga, Ashish Kumar Vyas, Anirudh K. Singh

    Background: The disease severity, ranging from being asymptomatic to having acute illness, and associated inflammatory responses has suggested that alterations in the gut microbiota may play a crucial role in the development of chronic disorders due to COVID-19 infection. This study describes gut microbiota dysbiosis in COVID-19 patients and its implications relating to the disease. Design: A cross sectional prospective study was performed on thirty RT-PCR-confirmed COVID-19 patients admitted to the All India Institute of Medical Sciences, Bhopal, India, between September 10 and 20, 2020. Ten healthy volunteers were recruited as the control group. IFN, TNF, and IL-21 profiling was conducted using plasma samples, and gut bacterial analysis was performed after obtaining the metagenomics data of stool samples. Results: Patients with a variable COVID-19 severity showed distinct gut microflora and peripheral interleukin-21 levels. A low Firmicute/Bacteroidetes ratio, caused by the depletion of the fibre-utilizing bacteria, F. prausnitzii, B. Plebius, and Prevotella, and an increase in Bacteroidetes has associated gut microbiota dysbiosis with COVID-19 disease severity. Conclusions: The loss of the functional attributes of signature commensals in the gut, due to dysbiosis, is a predisposing factor of COVID-19 pathophysiology.